PubRank

M Myśliwiec

Author PubWeight™ 23.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pneumomediastinum and subcutaneous emphysema--unusual complications of automated peritoneal dialysis. Perit Dial Int 2003 0.99
2 Kynurenine pathway - a new link between endothelial dysfunction and carotid atherosclerosis in chronic kidney disease patients. Adv Med Sci 2010 0.89
3 Compliance with lifestyle recommendations in kidney allograft recipients. Transplant Proc 2011 0.88
4 Concentration of three thrombin inhibitors in the nephrotic syndrome in adults. Nephron 1986 0.87
5 Interleukin-12 and tumour necrosis factor-alpha equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitus. Scand J Immunol 2008 0.86
6 Thyroid function and morphology in kidney transplant recipients, hemodialyzed, and peritoneally dialyzed patients. Transplant Proc 2003 0.85
7 Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus. J Hum Hypertens 2010 0.83
8 Erythrocyte sedimentation and soluble fibrin monomer complexes. Thromb Diath Haemorrh 1969 0.81
9 Translocation form of Wolf-Hirschhorn syndrome --assessment of recurrence rate probability. Adv Med Sci 2007 0.81
10 The hematocrit-corrected erythrocyte sedimentation rate can be useful in diagnosing inflammation in hemodialysis patients. Nephron 2001 0.80
11 Telmisartan lowers albuminuria in type 2 diabetic patients treated with angiotensin enzyme inhibitors. Adv Med Sci 2009 0.79
12 Cyclosporine A affects serotonergic mechanisms in uremic rats. Pol J Pharmacol 1997 0.79
13 Simvastain affects TAFI and thrombomodulin in CAPD patients. Thromb Haemost 2001 0.79
14 [Concentration of leptin in patients on hemodialysis and peritoneal dialysis]. Pol Arch Med Wewn 1999 0.78
15 Anthranilic acid-uraemic toxin damaged red cell's membrane. Int Urol Nephrol 2005 0.78
16 Soluble thrombomodulin: a marker of endothelial injury, an antithrombotic agent, or both? Med Sci Monit 2001 0.78
17 Over-dialysis plasma RANTES increase depends on heparin dose and cardiovascular disease status. Adv Med Sci 2013 0.78
18 A potent 5-hydroxytryptamine receptor (5-HT2A) antagonist, DV-7028, delays arterial thrombosis development in rats. Thromb Res 1998 0.77
19 Importance of serotonergic mechanisms in the thrombotic complications in hemodialyzed patients treated with erythropoietin. Nephron 2000 0.77
20 The in vivo effect of the collagen of kaolin-activated contact factor on blood clotting and fibrinolysis in rabbit. Bull Acad Pol Sci Biol 1967 0.77
21 Effects of endothelin-1 on aggregation of normal and uremic platelets. Pol J Pharmacol 1997 0.77
22 Renal artery resistance index, thyroid hormones, and thyroid volume in the early kidney transplants recipients. Transplant Proc 2006 0.77
23 Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome. Pol J Pharmacol 1997 0.77
24 Protein Z and vitamin K in kidney disease. Rocz Akad Med Bialymst 2004 0.77
25 Thyroid gland function in patients after renal transplantation. Transplant Proc 2002 0.76
26 Parvovirus B19 infection and IGF system components in relation to erythropoiesis in dialyzed patients and kidney transplant recipients. Transplant Proc 2002 0.76
27 Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients. Adv Med Sci 2006 0.76
28 [Bone metabolism in dialysis patient assessed by biochemical markers and densitometry]. Pol Arch Med Wewn 2003 0.76
29 Protein Z, a vitamin K-dependent protein in patients with renal failure. J Thromb Haemost 2003 0.76
30 The predictive value of arterial renal blood flow parameters in renal graft survival. Transplant Proc 2007 0.76
31 Anemia and erythrocytosis after kidney transplantation: a 5-year graft function and survival analysis. Transplant Proc 2009 0.76
32 Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients. Transplant Proc 2007 0.76
33 The status of BK polyomavirus replication in adult renal transplant recipients in northeastern Poland. Transplant Proc 2011 0.76
34 [Blood platelet function, plasma serotonin and lipid metabolism in patients with diabetic nephropathy]. Pol Arch Med Wewn 1995 0.76
35 Serum crosslaps correlations with serum ICTP and urine DPD in hemodialyzed and peritoneally dialyzed patients. Nephron 2001 0.75
36 Fungaemia due to Cryptococcus laurentii as a complication of immunosuppressive therapy--a case report. Adv Med Sci 2009 0.75
37 Correlations of new markers of bone formation and resorption in kidney transplant recipients. Transplant Proc 2003 0.75
38 Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients. Nephrol Dial Transplant 1993 0.75
39 [Erythropoietin and fibrinolysis in uremic patients]. Pol Arch Med Wewn 1993 0.75
40 [Nephrotoxicity of iodine containing contrast media]. Pol Tyg Lek 1989 0.75
41 Plasma fibrinogen level is an important determinant of prolonged euglobulin clot lysis time in hemodialysis patients. Clin Appl Thromb Hemost 2001 0.75
42 [A case of poisoning with aspartic acid]. Pol Arch Med Wewn 1969 0.75
43 [Tissue factor and tissue factor pathway inhibitor in peritonitis treated with dialysis]. Przegl Lek 2000 0.75
44 Brain abscess as a rare complication in a hemodialysed patient. Med Sci Monit 2001 0.75
45 [Evaluation of selected parameters of hemostasis in patients with nephrotic syndrome]. Przegl Lek 1994 0.75
46 [Blood platelets, prostaglandin and complement interactions in inflammation]. Przegl Lek 1982 0.75
47 [Effect of phenformin and stanozol administration on lipid metabolism in patients with occlusive vascular diseases]. Pol Tyg Lek 1972 0.75
48 The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis. Folia Haematol Int Mag Klin Morphol Blutforsch 1974 0.75
49 The influence of azathioprine on the behaviour of blood platelets in vitro. Folia Haematol Int Mag Klin Morphol Blutforsch 1976 0.75
50 The influence of long-term therapy with phenformin plus metanabol on blood fibrinolytic activity, platelet adhesiveness and lipid metabolism in patients with arteriosclerosis. Folia Haematol Int Mag Klin Morphol Blutforsch 1976 0.75
51 Plasma thromboxane B2 in haemodialysed patients. Folia Haematol Int Mag Klin Morphol Blutforsch 1985 0.75
52 The effect of mercury chloride intoxication on the intracellular distribution of plasminogen activator in dog kidney tissue. Bull Acad Pol Sci Biol 1968 0.75
53 [Pathogenesis of disorders of hemostasis in patients with chronic uremia]. Pol Arch Med Wewn 1983 0.75
54 [The role of tissue factor and its inhibitor in hemostasis]. Przegl Lek 1998 0.75
55 [Treatment of hemorrhagic diathesis in patients with chronic uremia]. Przegl Lek 1989 0.75
56 [Effect of heparin and venous stasis on the fibrinolytic activity of the blood]. Pol Tyg Lek 1986 0.75
57 [Platelet aggregation and P-selectin concentration in patients on peritoneal dialysis treated with erythropoietin]. Pol Arch Med Wewn 2001 0.75
58 Platelet adhesiveness in diabetics. Pol Med J 1970 0.75
59 Construction, expression and preliminary characterization of glycosylation mutants of human protein S. Pol J Pharmacol 1997 0.75
60 [Acute ethylene glycol poisoning treated with hemodialysis]. Wiad Lek 1983 0.75
61 [Effect of salicylates on the formation of platelet aggregates]. Pol Tyg Lek 1973 0.75
62 [Parameters of blood clotting and fibrinolysis in patients with acute cerebrovascular diseases]. Rocz Akad Med Im Juliana Marchlewskiego Bialymst 1975 0.75
63 [Fibrinolytic activity of deep and superficial crural veins]. Pol Tyg Lek 1986 0.75
64 [Anticoagulants in hemodialysis therapy]. Przegl Lek 1996 0.75
65 Hemostasis, platelet functions, serotonin and serum lipids during omega-3 fatty acid treatment in patients with glomerulonephritis. Nephron 1998 0.75
66 [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia]. Pol Merkur Lekarski 1996 0.75
67 Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients. Adv Med Sci 2013 0.75
68 [Role of the kidneys in the pathogenesis of acute liver insufficiency]. Przegl Epidemiol 1983 0.75
69 [Influence of some vasoactive drugs on blood platelet aggregation]. Pol Tyg Lek 1971 0.75
70 [Lipid metabolism and fibrinolysis in diabetic nephropathy in the course of diabetes type II]. Pol Arch Med Wewn 1995 0.75
71 Endogenous neurotoxine-quinolinic acid is increased in renal allograft recipients. Transplant Proc 2002 0.75
72 [Thrombotic theory of growth and metastasis of malignant neoplasms]. Pol Arch Med Wewn 1967 0.75
73 [Antiplatelet drugs]. Przegl Lek 1992 0.75
74 [Effect of cigarette smoking on platelet adhesiveness and aggregation]. Pol Tyg Lek 1973 0.75
75 [Effect of mercury diuretic Novurit on fibrinolysis]. Pol Tyg Lek 1973 0.75
76 Comparison of different assays for von Willebrand factor in hemodialysis patients. Haemostasis 2001 0.75
77 Aluminium and beta-2-microglobulin in kidney transplant recipients. Transplant Proc 2002 0.75
78 [Fibrinolytic and peripheral serotonergic system in patients with glomerulonephritis]. Przegl Lek 1995 0.75
79 [Use of low-molecular weight heparin during hemodialysis]. Pol Merkur Lekarski 1997 0.75
80 [Serotonin levels in the blood of patients with terminal renal failure]. Pol Tyg Lek 1986 0.75
81 Shortening of bleeding time after intranasal administration of 1-deamino-8-D-arginine vasopressin to patients with chronic uremia. Folia Haematol Int Mag Klin Morphol Blutforsch 1986 0.75
82 [Value of intermediate compounds in ultrafiltration depending on the type of dialysis and their effect on fibrinolytic activity]. Pol Tyg Lek 1991 0.75
83 [Platelet adhesiveness and fibrinolysis in Raynaud's disease]. Wiad Lek 1972 0.75
84 [Nephrolithiasis in a HIV infected patient treated with indinavir]. Przegl Lek 2001 0.75
85 [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]]. Pol Tyg Lek 1991 0.75
86 Effect of experimental ileus on blood coagulability of peripheral venous and portal blood in dogs. Pol Med J 1969 0.75
87 [Effect of heparin and prostacyclin on blood platelet activity]. Pol Tyg Lek 1983 0.75
88 [Early thrombocytopenia after administration of heparin in patients with chronic renal failure]. Pol Tyg Lek 1986 0.75
89 [Effect of immunosuppressive treatment on the blood's fibrinolytic activity]. Pol Tyg Lek 1975 0.75
90 [Effect of immunosuppressive y treatment on blood clotting and fibrinolysis]. Wiad Lek 1977 0.75
91 [Altered circadian rhythm of platelet aggregation in patients on longterm hemodialysis]. Przegl Lek 1997 0.75
92 [Tissue factor and inhibitor of the blood coagulation pathway in nephrotic syndrome]. Pol Arch Med Wewn 1999 0.75
93 [Blood fibrinolytic activity in patients following myocardial infarct]. Pol Tyg Lek 1971 0.75
94 [Dysfunction of platelets in uremia]. Przegl Lek 1999 0.75
95 [Ketanserin decreases erythropoietin concentration in hemodialyzed patients on rHuEPO therapy]. Pol Arch Med Wewn 1994 0.75
96 [Effect of treating glomerulonephritis with omega 3 fatty acids for selected parameters of hemostasis, blood platelet function and lipid metabolism]. Przegl Lek 1996 0.75
97 [Role of blood platelets in inflammatory processes]. Pol Tyg Lek 1982 0.75
98 [Fibrinogen degradation products in cerebrospinal fluid in children]. Pediatr Pol 1973 0.75
99 Prophylaxis of recurrent venous thrombosis with long-term enhancement of fibrinolysis. Folia Haematol Int Mag Klin Morphol Blutforsch 1979 0.75
100 Desmopressin induces decrease in platelet count in uremia. Thromb Haemost 1986 0.75
101 Normal response to uraemic platelets to thromboxane A2 agonist. Nephron 1983 0.75
102 Effects of long-term treatment with simvastatin on some hemostatic parameters in continuous ambulatory peritoneal dialysis patients. Am J Nephrol 2001 0.75
103 Thrombin activatable fibrinolysis inhibitor (TAFI) in stable angina pectoris patients undergoing coronary artery bypass grafting (CABG). Rocz Akad Med Bialymst 2005 0.75
104 Parathyroid gland sonography in relation to markers of bone metabolism in kidney transplant recipients. Transplant Proc 2002 0.75
105 Leptinaemia in patients dialysed with different buffers and dialysis membranes. Nephrol Dial Transplant 1999 0.75
106 [HIV nephropathy and other kidney diseases in patients with human immunodeficiency virus infections]. Przegl Lek 2000 0.75
107 [Platelet adhesiveness in patients with a history of past myocardial infarct]. Pol Tyg Lek 1972 0.75
108 Peripheral serotonergic system in hemodialyzed and peritoneally dialyzed patients. Nephron 2000 0.75
109 [Treatment of acute leukemias in adults. IV. Treatment results on 375 patients at 9 hematology centers]. Acta Haematol Pol 1982 0.75
110 Correlations between new markers of bone formation versus bone resorption in kidney transplant recipients. Transplant Proc 2002 0.75
111 [New concepts in the pathogenesis of essential hypertension]. Przegl Lek 1999 0.75
112 [Fibrinolysis, blood coagulation and cigarette smoking]. Pol Tyg Lek 1981 0.75
113 [Effect of bronchodilators on the aggregation and adhesiveness of platelets in patients with bronchial asthma]. Pol Arch Med Wewn 1971 0.75
114 [Effect of azathioprine (Imuran) on the behavior of blood platelets in vitro]. Pol Tyg Lek 1975 0.75
115 [Blood platelet adhesiveness in diabetic patients]. Pol Arch Med Wewn 1970 0.75
116 The behaviour of the platelet-leukocyte aggregation in thrombotic conditions. Folia Haematol Int Mag Klin Morphol Blutforsch 1975 0.75
117 [Effect of troxerutin on platelet aggregation in patients with arteriosclerosis]. Pol Tyg Lek 1983 0.75
118 [Various aspects of the regulation and role of fibrinolysis in the organism]. Rocz Akad Med Im Juliana Marchlewskiego Bialymst 1982 0.75
119 [Blood platelet function in patients with chronic renal failure]. Pol Arch Med Wewn 1988 0.75
120 [Studies of the fibrinolytic activity of the blood in diabetics]. Pol Tyg Lek 1970 0.75
121 [Homocysteine--new risk factor for progression of atherosclerosis and its complications]. Pol Merkur Lekarski 2001 0.75
122 [Various aspects of the role and regulation of fibrinolysis in the body]. Pol Tyg Lek 1978 0.75
123 [Effect of inhibition of prostaglandin synthesis on plasma renin activity during hemodialysis]. Pol Tyg Lek 1983 0.75
124 [Calcium blockers and their their present application]. Przegl Lek 1999 0.75
125 The role of blood platelets in glomerulonephritis. Przegl Lek 1998 0.75
126 [Etiopathogenesis of thrombotic microangiopathy in the light of new studies]. Pol Tyg Lek 1983 0.75
127 L-Carnitine effects on anemia in uremic rats treated with erythropoietin. Nephron 1999 0.75
128 Altered circadian rhythm of platelet aggregation in hemodialyzed patients. Nephron 1997 0.75
129 Fibrin stabilizing factor (factor XIII) consumption as an indicator of disseminated intravascular coagulation (DIC). Folia Haematol Int Mag Klin Morphol Blutforsch 1977 0.75
130 [Antithrombin III activity during hemodialysis]. Pol Arch Med Wewn 1983 0.75
131 Soluble thrombomodulin is associated with viral hepatitis, blood pressure, and medications in haemodialysis patients. Nephrol Dial Transplant 2001 0.75
132 [Current concepts of diagnosis and treatment of thrombotic thrombocytic purpura]. Przegl Lek 1984 0.75
133 The effect of fibrinogen degradation products on plasmin activity. Thromb Diath Haemorrh 1973 0.75
134 Effect of DV-7028, a novel serotonin 5-HT2 receptor antagonist on the cardiovascular system in rats. Acta Physiol Hung 1996 0.75
135 [Platelet aggregation during the recombinant human erythropoietin (rHuEPO) treatment of patients with uremia]. Pol Arch Med Wewn 1992 0.75
136 [Selected parameters of bone metabolism in hemodialyzed and peritoneally dialyzed patients]. Przegl Lek 2000 0.75
137 Is there any relation between thyroid gland function and kidney transplant function? Transplant Proc 2003 0.75
138 [TAFI--thrombin activated fibrinolysis inhibitor ]. Przegl Lek 2001 0.75
139 The influence of some drugs on platelet aggregation and adhesion. Acta Univ Carol Med Monogr 1972 0.75
140 Desmopressin induces decrease in platelet serotonin content in uremia. Thromb Haemost 1989 0.75
141 Correlation between carotid intima-media thickness and hematocrit and hemoglobin values in renal transplant recipients. Clin Transplant 2001 0.75
142 Influence of MCI-9042, a novel 5-HT2 receptor blocker on blood vessels of the rat. Acta Physiol Hung 1996 0.75
143 Leptin and serum erythropoietin in hemodialyzed and peritoneally dialyzed uremic patients during rHuEPO therapy. Am J Nephrol 2000 0.75
144 Clinical investigations on long-term activation of fibrinolysis by anabolic steroids. Folia Haematol Int Mag Klin Morphol Blutforsch 1986 0.75
145 [Possible role of serotonin in hemostatic the mechanism of action of desmopressin (DDAVP) in patients with uremia]. Pol Arch Med Wewn 1993 0.75
146 Patients on peritoneal dialysis but not on hemodialysis have elevated concentration and activity of thrombin-activatable fibrinolysis inhibitor. Thromb Res 2001 0.75
147 Tissue factor pathway inhibitor and tissue factor in HD and CAPD. Nephrol Dial Transplant 1998 0.75
148 Hemostasis in chronic renal failure. Rocz Akad Med Bialymst 2005 0.75
149 [Effect of experimental intestinal obstruction on coagulability of peripheral venous and portal blood in the dog]. Pol Arch Med Wewn 1968 0.75
150 [Plasminogen activator in various human veins]. Pol Tyg Lek 1986 0.75
151 Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease. Bibl Anat 1977 0.75